Type I interferons in bacterial infections: Taming of myeloid cells and possible implications for autoimmunity

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Eshleman, Emily M ^a   Lenz, Laurel L ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Autoimmunity; Bacterial pathogens; Immune suppression; Interferon receptors; Interferons; Macrophage activation

Indexed keywords

BETA INTERFERON; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RECOMBINANT INTERFERON; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; BONE MARROW CELL; CELL PROLIFERATION; DRUG MECHANISM; FRANCISELLA NOVICIDA; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREGULATION; LISTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VIRAL CLEARANCE;

EID: 84918801828     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00431     Document Type: Article

References (137)

1. Abdullah, Z., Schlee, M., Roth, S., Mraheil, M. A., Barchet, W., Böttcher, J., Hain, T., Geiger, S., Hayakawa, Y., Fritz, J. H., et al. (2012). RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J. 31, 4153-64. doi:10.1038/emboj.2012.274.
2. Antonelli, L., Rothfuchs, A., Goncalves, R., Roffe, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., and Sher, A. (2010). Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120, 1674-82. doi:10.1172/JCI40817DS1.
3. Aubry, C., Corr, S. C., Wienerroither, S., Goulard, C., Jones, R., Jamieson, A. M., Decker, T., O'Neill, L. A. J., Dussurget, O., and Cossart, P. (2012). Both TLR2 and TRIF contribute to interferon-ß production during Listeria infection. PLoS One 7, e33299. doi:10.1371/journal.pone.0033299.
4. Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M., and Portnoy, D. A. (2004). Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527-33. doi:10.1084/jem.20040976.
5. Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. a, Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100, 2610-5. doi:10.1073/pnas.0337679100.
6. Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C., and Goodell, M. a (2010). Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465, 793-7. doi:10.1038/nature09135.
7. Bennett, L., Palucka, a K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., and Pascual, V. (2003). Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-23. doi:10.1084/jem.20021553.
8. Berg, R. E., Crossley, E., Murray, S., and Forman, J. (2003). Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198, 1583-93. doi:10.1084/jem.20031051.
9. Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. a a, Oni, T., Wilkinson, K. a, Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-7. doi:10.1038/nature09247.
10. Bhat, N., Wright, J. G., Broder, K. R., Murray, E. L., Greenberg, M. E., Glover, M. J., Likos, A. M., Posey, D. L., Klimov, A., Lindstrom, S. E., et al. (2005). Influenza-associated deaths among children in the United States, 2003-2004. N. Engl. J. Med. 353, 2559-67. doi:10.1056/NEJMoa051721.
11. Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., and Stark, G. R. (2007). Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975-90. doi:10.1038/nrd2422.
12. Van Boxel-Dezaire, A. H. H., Rani, M. R. S., and Stark, G. R. (2006). Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361-72. doi:10.1016/j.immuni.2006.08.014.
13. Bracarda, S., Eggermont, A. M. M., and Samuelsson, J. (2010). Redefining the role of interferon in the treatment of malignant diseases. Eur. J. Cancer 46, 284-97. doi:10.1016/j.ejca.2009.10.013.
14. Brzoza-Lewis, K. L., Hoth, J. J., and Hiltbold, E. M. (2012). Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes. Cell. Immunol. 273, 41-51. doi:10.1016/j.cellimm.2011.11.008.
15. Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., and Vance, R. E. (2011). STING is a direct innate immune sensor of cyclic di-GMP. Nature 478, 515-8. doi:10.1038/nature10429.
16. Carr, K. D., Sieve, A. N., Indramohan, M., Break, T. J., Lee, S., and Berg, R. E. (2011). Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur. J. Immunol. 41, 2666-76. doi:10.1002/eji.201041363.
17. Carrero, J. A., Calderon, B., and Unanue, E. R. (2006). Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203, 933-40. doi:10.1084/jem.20060045.
18. Carrero, J. A., Calderon, B., and Unanue, E. R. (2004). Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200, 535-40. doi:10.1084/jem.20040769.
19. Chin, A. I., Dempsey, P. W., Bruhn, K., Miller, J. F., Xu, Y., and Cheng, G. (2002). Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-4. doi:10.1038/416190a.
20. Cooper, C. L., Al-Bedwawi, S., Lee, C., and Garber, G. (2006). Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin. Infect. Dis. 42, 1674-8. doi:10.1086/504386.
21. Cousens, L., Orange, J., Su, H., and Biron, C. (1997). Interferon-a/b inhibition of interleukin 12 and interferon-g production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. U. S. A. 94, 634-639.
22. Decker, T., Müller, M., and Stockinger, S. (2005). The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5, 675-87. doi:10.1038/nri1684.
23. Desvignes, L., Wolf, A. J., and Ernst, J. D. (2012). Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 188, 6205-15. doi:10.4049/jimmunol.1200255.
24. Dighe, A. S., Campbell, D., Hsieh, C. S., Clarke, S., Greaves, D. R., Gordon, S., Murphy, K. M., and Schreiber, R. D. (1995). Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657-66. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7584155.
25. Emmerling, P., Finger, H., and Bockemühl, J. (1975). Listeria monocytogenes infection in nude mice. Infect. Immun. 12, 437-9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=421378&tool=pmcentrez&rend ertype=abstract.
26. Fehr, B. T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., and Zinkernagel, R. M. (1997). Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis. J. Exp. Med. 185, 921-31.
27. Fung, K. Y., Mangan, N. E., Cumming, H., Horvat, J. C., Mayall, J. R., Stifter, S. a, De Weerd, N., Roisman, L. C., Rossjohn, J., Robertson, S. a, et al. (2013). Interferon-ε protects the female reproductive tract from viral and bacterial infection. Science 339, 1088-92. doi:10.1126/science.1233321.
28. Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. a, Romero, P., et al. (2011). Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213-23. doi:10.1016/j.immuni.2011.02.006.
29. Hagmann, C. A., Herzner, A. M., Abdullah, Z., Zillinger, T., Jakobs, C., Schuberth, C., Coch, C., Higgins, P. G., Wisplinghoff, H., Barchet, W., et al. (2013). RIG-I detects triphosphorylated RNA of Listeria monocytogenes during infection in non-immune cells. PLoS One 8, e62872. doi:10.1371/journal.pone.0062872.
30. Hall, J. C., and Rosen, A. (2010). Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6, 40-9. doi:10.1038/nrrheum.2009.237.
31. Hansen, K., Prabakaran, T., Laustsen, A., Jørgensen, S. E., Rahbæk, S. H., Jensen, S. B., Nielsen, R., Leber, J. H., Decker, T., Horan, K. a, et al. (2014). Listeria monocytogenes induces IFNß expression through an IFI16-, cGAS- and STING-dependent pathway. EMBO J. 33, 1654-66. doi:10.15252/embj.201488029.
32. Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J.- D., Iwakura, Y., Metzger, D. W., et al. (2010). Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J. Immunol. 184, 3755-67. doi:10.4049/jimmunol.0902065.
33. Huang, R. P., Fan, Y., deBelle, I., Ni, Z., Matheny, W., and Adamson, E. D. (1998). Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ. 5, 96-106. doi:10.1038/sj.cdd.4400322.
34. Humann, J., and Lenz, L. L. (2010). Activation of Naive NK Cells in Response to Listeria monocytogenes Requires IL-18 and Contact with Infected Dendritic Cells. J. Immunol. 184, 5172-5178. doi:10.4049/jimmunol.0903759.
35. Hunn, J. P., Feng, C. G., Sher, A., and Howard, J. C. (2011). The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens. Mamm. Genome 22, 43-54. doi:10.1007/s00335-010-9293-3.
36. Ireton, K. (2007). Entry of the bacterial pathogen Listeria monocytogenes into mammalian cells. Cell. Microbiol. 9, 1365-75. doi:10.1111/j.1462-5822.2007.00933.x.
37. Ishihara, T., Aga, M., Hino, K., Ushio, C., Taniguchi, M., Iwaki, K., Ikeda, M., and Kurimoto, M. (2005). Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed. Res. 26, 179-85. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16152734.
38. Ishikawa, H., Ma, Z., and Barber, G. N. (2009). STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-92. doi:10.1038/nature08476.
39. Jin, L., Hill, K. K., Filak, H., Mogan, J., Knowles, H., Zhang, B., Perraud, A.-L., Cambier, J. C., and Lenz, L. L. (2011). MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J. Immunol. 187, 2595-601. doi:10.4049/jimmunol.1100088.
40. Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., and Raz, E. (2005). Toll-like receptor 9 - induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695-702. doi:10.1172/JCI200522996DS1.
41. Kearney, S., Delgado, C., and Lenz, L. L. (2012). Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections. Immunol. Res. 55, 187- 200. doi:10.1007/s12026-012-8362-y.
42. Kearney, S. J., Delgado, C., Eshleman, E. M., Hill, K. K., O'Connor, B. P., and Lenz, L. L. (2013). Type I IFNs Downregulate Myeloid Cell IFN-γ Receptor by Inducing Recruitment of an Early Growth Response 3/NGFI-A Binding Protein 1 Complex That Silences ifngr1 Transcription. J. Immunol. 191, 3384-92. doi:10.4049/jimmunol.1203510.
43. Kernbauer, E., Maier, V., Rauch, I., Müller, M., and Decker, T. (2013). Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes. PLoS One 8, e65007. doi:10.1371/journal.pone.0065007.
44. Kim, B.-H., Shenoy, A. R., Kumar, P., Bradfield, C. J., and MacMicking, J. D. (2012). IFN inducible GTPases in host cell defense. Cell Host Microbe 12, 432-44. doi:10.1016/j.chom.2012.09.007.
45. Kirou, K. a, Lee, C., George, S., Louca, K., Peterson, M. G. E., and Crow, M. K. (2005). Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52, 1491-503. doi:10.1002/art.21031.
46. Kobayashi, K., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. a, Medzhitov, R., and Flavell, R. a (2002). RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-9. doi:10.1038/416194a.
47. Kumatori, A., Yang, D., Suzuki, S., and Nakamura, M. (2002). Cooperation of STAT-1 and IRF- 1 in interferon-gamma-induced transcription of the gp91(phox) gene. J. Biol. Chem. 277, 9103-11. doi:10.1074/jbc.M109803200.
48. Kurihara, T., Warr, G., Loy, J., and Bravo, R. (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186, 1757-62. doi:10.1084/jem.186.10.1757.
49. Leber, J. H., Crimmins, G. T., Raghavan, S., Meyer-Morse, N. P., Cox, J. S., and Portnoy, D. A. (2008). Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4, e6. doi:10.1371/journal.ppat.0040006.
50. Lee, J., Rachmilewitz, D., and Raz, E. (2006). Homeostatic effects of TLR9 signaling in experimental colitis. Ann. N. Y. Acad. Sci. 1072, 351-5. doi:10.1196/annals.1326.022.
51. Lee, S. H., Carrero, J. a, Uppaluri, R., White, J. M., Archambault, J. M., Lai, K. S., Chan, S. R., Sheehan, K. C. F., Unanue, E. R., and Schreiber, R. D. (2013). Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1). J. Immunol. 191, 4223-34. doi:10.4049/jimmunol.1300910.
52. Lippmann, J., Rothenburg, S., Deigendesch, N., Eitel, J., Meixenberger, K., van Laak, V., Slevogt, H., N'guessan, P. D., Hippenstiel, S., Chakraborty, T., et al. (2008). IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell. Microbiol. 10, 2579-88. doi:10.1111/j.1462- 5822.2008.01232.x.
53. Loo, Y.-M., and Gale, M. (2011). Immune signaling by RIG-I-like receptors. Immunity 34, 680- 92. doi:10.1016/j.immuni.2011.05.003.
54. Lykens, J. E., Terrell, C. E., Zoller, E. E., Divanovic, S., Trompette, A., Karp, C. L., Aliberti, J., Flick, M. J., and Jordan, M. B. (2010). Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 184, 877- 85. doi:10.4049/jimmunol.0902346.
55. MacMicking, J., Xie, Q., and Nathan, C. (1997). N itric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-50. doi:10.1146/annurev.immunol.15.1.323.
56. MacNamara, K. C., Oduro, K., Martin, O., Jones, D. D., McLaughlin, M., Choi, K., Borjesson, D. L., and Winslow, G. M. (2011). Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling. J. Immunol. 186, 1032-43. doi:10.4049/jimmunol.1001893.
57. Malireddi, R. K. S., and Kanneganti, T.-D. (2013). Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection. Front. Cell. Infect. Microbiol. 3, 1-11. doi:10.3389/fcimb.2013.00077.
58. Manca, C., Tsenova, L., Bergtold, a, Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., and Kaplan, G. (2001). Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. U. S. A. 98, 5752-7. doi:10.1073/pnas.091096998.
59. Manca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., and Kaplan, G. (2005). Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interf. cytokine Res. 701, 694-701. doi:10.1089/jir.2005.25.694.
60. Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F., Gambuzza, M., Macrì, G., Ruggeri, A., et al. (2007). Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria. J. Immunol. 178, 3126-3133.
61. Mannon, P. J., Hornung, R. L., Yang, Z., Yi, C., Groden, C., Friend, J., Yao, M., Strober, W., and Fuss, I. J. (2011). Suppression of inflammation in ulcerative colitis by interferon-ß-1a is accompanied by inhibition of IL-13 production. Gut 60, 449-55. doi:10.1136/gut.2010.226860.
62. Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., and Sher, A. (2011). Innate and adaptive interferons suppress IL-1a and IL- 1ß production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023-34. doi:10.1016/j.immuni.2011.12.002.
63. Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S. D., Wilson, M. S., Cheever, A., Kugler, D., Hieny, S., Caspar, P., Núñez, G., et al. (2010). Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326-30. doi:10.4049/jimmunol.0904189.
64. McCaffrey, R. L., Fawcett, P., O'Riordan, M., Lee, K.-D., Havell, E. A., Brown, P. O., and Portnoy, D. A. (2004). A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc. Natl. Acad. Sci. U. S. A. 101, 11386-91. doi:10.1073/pnas.0403215101.
65. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., and Tschopp, J. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-72. doi:10.1038/nature04193.
66. Monroe, K. M., McWhirter, S. M., and Vance, R. E. (2009). Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog. 5, e1000665. doi:10.1371/journal.ppat.1000665.
67. Morens, D. M., Taubenberger, J. K., and Fauci, A. S. (2008). Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-70. doi:10.1086/591708.
68. Mostowy, S., and Cossart, P. (2009). Cytoskeleton rearrangements during Listeria infection: clathrin and septins as new players in the game. Cell Motil. Cytoskeleton 66, 816-23. doi:10.1002/cm.20353.
69. Mullen, L., Adams, G., Foster, J., Vessillier, S., Köster, M., Hauser, H., Layward, L., Gould, D., and Chernajovsky, Y. (2013). A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints. Ann. Rheum. Dis. doi:10.1136/annrheumdis-2013-203513.
70. Nagarajan, U. M., Prantner, D., Sikes, J. D., Andrews, C. W., Goodwin, A. M., Nagarajan, S., and Darville, T. (2008). Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76, 4642-8. doi:10.1128/IAI.00629-08.
71. Nakamura, S., Davis, K. M., and Weiser, J. N. (2011). Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657-3665. doi:10.1172/JCI57762.of.
72. Navarini, A. a, Recher, M., Lang, K. S., Georgiev, P., Meury, S., Bergthaler, A., Flatz, L., Bille, J., Landmann, R., Odermatt, B., et al. (2006). Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. U. S. A. 103, 15535-9. doi:10.1073/pnas.0607325103.
73. Nickol, a D., and Bonventre, P. F. (1977). Anomalous high native resistance to athymic mice to bacterial pathogens. Infect. Immun. 18, 636-45. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=421283&tool=pmcentrez&rend ertype=abstract.
74. Nikolaus, S., Rutgeerts, P., Fedorak, R., Steinhart, a H., Wild, G. E., Theuer, D., Möhrle, J., and Schreiber, S. (2003). Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut 52, 1286-90. doi:10.1136/gut.52.9.1286.
75. Novikov, A., Cardone, M., Thompson, R., Shenderov, K., Kirschman, K. D., Mayer-Barber, K. D., Myers, T. G., Rabin, R. L., Trinchieri, G., Sher, A., et al. (2011). Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1ß production in human macrophages. J. Immunol. 187, 2540-7. doi:10.4049/jimmunol.1100926.
76. O'Connell, R. M., Saha, S. K., Vaidya, S. a, Bruhn, K. W., Miranda, G. a, Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004). Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200, 437-45. doi:10.1084/jem.20040712.
77. O'Connell, R., Vaidya, S., Perry, A. K., Saha, S. K., Dempsey, P. W., and Cheng, G. (2005). Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TANK-binding kinase. J. Immunol. 174, 1602-1607. Available at: http://www.jimmunol.org/content/174/3/1602.short [Accessed December 3, 2013].
78. O'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J., and Baraban, J. M. (1999). The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22, 167-73. doi:10.1016/S0166-2236(98)01343-5.
79. Park, J.-H., Kim, Y.-G., McDonald, C., Kanneganti, T.-D., Hasegawa, M., Body-Malapel, M., Inohara, N., and Núñez, G. (2007). RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178, 2380-6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17277144.
80. Pestka, S. (2007). The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 282, 20047-51. doi:10.1074/jbc.R700004200.
81. Platanias, L. C. (2005). Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-86. doi:10.1038/nri1604.
82. Plumlee, C. R., Lee, C., Beg, A. a, Decker, T., Shuman, H. a, and Schindler, C. (2009). Interferons direct an effective innate response to Legionella pneumophila infection. J. Biol. Chem. 284, 30058-66. doi:10.1074/jbc.M109.018283.
83. Portnoy, D., Jacks, P., and Hinrichs, D. (1988). Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 167, 1459-71. Available at: http://jem.rupress.org/content/167/4/1459.abstract [Accessed January 23, 2014].
84. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K.-P., Hanisch, U.-K., Raasch, J., Merkler, D., Detje, C., Gutcher, I., Mages, J., et al. (2008). Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28, 675-86. doi:10.1016/j.immuni.2008.03.011.
85. Qiu, H., Fan, Y., Joyee, a. G., Wang, S., Han, X., Bai, H., Jiao, L., Van Rooijen, N., and Yang, X. (2008). Type I IFNs Enhance Susceptibility to Chlamydia muridarum Lung Infection by Enhancing Apoptosis of Local Macrophages. J. Immunol. 181, 2092-2102. doi:10.4049/jimmunol.181.3.2092.
86. Rauch, I., Hainzl, E., Rosebrock, F., Heider, S., Schwab, C., Stoiber, D., Wagner, M., Schleper, C., Loy, A., Urich, T., et al. (2014). Type I interferons have opposing effects during the emergence and recovery phases of colitis. Eur. J. Cancer, 1-40. doi:10.1002/eji.201344401.This.
87. Rayamajhi, M., Humann, J., Kearney, S., Hill, K. K., and Lenz, L. L. (2010a). Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence 1, 418-422. doi:10.1084/jem.20091746.ype.
88. Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K., and Lenz, L. L. (2010b). Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN gamma. J. Exp. Med. 207, 327-37. doi:10.1084/jem.20091746.
89. Reith, W., LeibundGut-Landmann, S., and Waldburger, J.-M. (2005). Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5, 793-806. doi:10.1038/nri1708.
90. Reutterer, B., Stockinger, S., Pilz, A., Soulat, D., Kastner, R., Westermayer, S., Rülicke, T., Müller, M., and Decker, T. (2008). Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence. Cell. Microbiol. 10, 1116-29. doi:10.1111/j.1462- 5822.2007.01114.x.
91. Rhee, I., and Veillette, A. (2012). Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat. Immunol. 13, 439-47. doi:10.1038/ni.2246.
92. Richer, E., Prendergast, C., Zhang, D.-E., Qureshi, S. T., Vidal, S. M., and Malo, D. (2010). N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-aß signaling and suppresses STAT4-induced IFN-γ production, resulting in increased susceptibility to Salmonella typhimurium. J. Immunol. 185, 3593- 601. doi:10.4049/jimmunol.1000890.
93. Roomer, R., Hansen, B. E., Janssen, H. L. a, and de Knegt, R. J. (2010). Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. Hepatology 52, 1225-31. doi:10.1002/hep.23842.
94. Roth, K. M., Gunn, J. S., Lafuse, W., and Satoskar, A. R. (2009). Francisella inhibits STAT1- mediated signaling in macrophages and prevents activation of antigen-specific T cells. Int. Immunol. 21, 19-28. doi:10.1093/intimm/dxn119.
95. Sasaki, T., Mieno, M., Udono, H., Yamaguchi, K., Usui, T., Hara, K., Shiku, H., and Nakayama, E. (1990). Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection. J. Exp. Med. 171, 1141-54. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2187836&tool=pmcentrez&rendertype=abstract.
96. Sauer, J.-D., Sotelo-Troha, K., von Moltke, J., Monroe, K. M., Rae, C. S., Brubaker, S. W., Hyodo, M., Hayakawa, Y., Woodward, J. J., Portnoy, D. a, et al. (2011). The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79, 688-94. doi:10.1128/IAI.00999-10.
97. Schneider, W. M., Chevillotte, M. D., and Rice, C. M. (2014). Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513-45. doi:10.1146/annurev-immunol-032713-120231.
98. Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 164-89. doi:10.1189/jlb.0603252.Journal.
99. Serbina, N. V, Jia, T., Hohl, T. M., and Pamer, E. G. (2008). Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-52. doi:10.1146/annurev.immunol.26.021607.090326.
100. Serbina, N. V, and Pamer, E. G. (2006). Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-7. doi:10.1038/ni1309.
101. Seth, R. B., Sun, L., Ea, C.-K., and Chen, Z. J. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-82. doi:10.1016/j.cell.2005.08.012.
102. Shah, K. M., Stewart, S. E., Wei, W., Woodman, C. B. J., O'Neil, J. D., Dawson, C. W., and Young, L. S. (2009). The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 28, 3903-14. doi:10.1038/onc.2009.249.
103. Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., and Deng, J. C. (2009). Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910-20. doi:10.1172/JCI35412.1910.
104. Shi, C., Hohl, T. M., Leiner, I., Equinda, M. J., Fan, X., and Pamer, E. G. (2011). Ly6G+ neutrophils are dispensable for defense against systemic Listeria monocytogenes infection. J. Immunol. 187, 5293-8. doi:10.4049/jimmunol.1101721.
105. Simonsen, L. (1999). The global impact of influenza on morbidity and mortality. Vaccine 17 Suppl 1, S3-10. doi:10.1016/S0264-410X(99)00099-7.
106. Singhal, A., Jaiswal, A., Arora, V. K., and Prasad, H. K. (2007). Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism. Infect. Immun. 75, 2500-10. doi:10.1128/IAI.01743-06.
107. Soudja, S. M., Ruiz, A. L., Marie, J. C., and Lauvau, G. (2012). Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37, 549-62. doi:10.1016/j.immuni.2012.05.029.
108. Soulat, D., Bauch, A., Stockinger, S., Superti-Furga, G., and Decker, T. (2006). Cytoplasmic Listeria monocytogenes stimulates IFN-beta synthesis without requiring the adapter protein MAVS. FEBS Lett. 580, 2341-2346. doi:10.1016/j.febslet.2006.03.057.
109. Stetson, D. B., and Medzhitov, R. (2006). Recognition of cytosolic DNA activates an IRF3- dependent innate immune response. Immunity 24, 93-103. doi:10.1016/j.immuni.2005.12.003.
110. Stockinger, S., Reutterer, B., Schaljo, B., Schellack, C., Brunner, S., Materna, T., Yamamoto, M., Akira, S., Taniguchi, T., Murray, P. J., et al. (2004). IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2- independent mechanism. J. Immunol. 173, 7416-25. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15585867.
111. Sun, Q., Sun, L., Liu, H.-H., Chen, X., Seth, R. B., Forman, J., and Chen, Z. J. (2006). The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24, 633-42. doi:10.1016/j.immuni.2006.04.004.
112. Swirnoff, A., and Milbrandt, J. (1995). DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Biol. 15, 2275-87. Available at: http://mcb.asm.org/content/15/4/2275.short [Accessed May 12, 2014].
113. Tak, P., Hart, B., and Kraan, M. (1999). The effects of interferon beta treatment on arthritis. Rheumatology 38, 362-369. doi:10.1093/rheumatology/38.4.362.
114. Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001). IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-55. doi:10.1146/annurev.immunol.19.1.623.
115. Taylor, G. a, Feng, C. G., and Sher, A. (2007). Control of IFN-gamma-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases). Microbes Infect. 9, 1644-51. doi:10.1016/j.micinf.2007.09.004.
116. Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., and Issazadeh-Navikas, S. (2003). IFN-B Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis. J. Immunol. 170, 4776- 4784. doi:10.4049/jimmunol.170.9.4776.
117. Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., de la Torre, J. C., and Oldstone, M. B. a (2013). Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207-11. doi:10.1126/science.1235214.
118. Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly-Scumpia, K., Chun, R., Iyer, S. S., et al. (2013). Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339, 1448-53. doi:10.1126/science.1233665.
119. Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., et al. (2011). Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell 146, 621-32. doi:10.1016/j.cell.2011.06.048.
120. Unterholzner, L., Keating, S. E., Baran, M., Horan, K. a, Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010). IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004. doi:10.1038/ni.1932.
121. Vabret, N., and Blander, J. M. (2013). Sensing Microbial RNA in the Cytosol. Front. Immunol. 4, 468. doi:10.3389/fimmu.2013.00468.
122. Wang, Y., Shaked, I., Stanford, S. M., Zhou, W., Curtsinger, J. M., Mikulski, Z., Shaheen, Z. R., Cheng, G., Sawatzke, K., Campbell, A. M., et al. (2013). The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity 39, 111-22. doi:10.1016/j.immuni.2013.06.013.
123. Waubant, E., Vukusic, S., Gignoux, L., Dubief, F. D., Achiti, I., Blanc, S., Renoux, C., and Confavreux, C. (2003). Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology 61, 184-189. doi:10.1212/01.WNL.0000078888.07196.0B.
124. Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., and Brooks, D. G. (2013). Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection. Science (80-.). 340, 202-207. doi:10.1126/science.1235208.
125. Witte, C. E., Whiteley, A. T., Burke, T. P., Sauer, J.-D., Portnoy, D. A., and Woodward, J. J. (2013). Cyclic di-AMP Is Critical for Listeria monocytogenes Growth, Cell Wall Homeostasis, and Establishment of Infection. MBio 4, e00282-13. doi:10.1128/mBio.00282-13.Editor.
126. Woodward, J. J., Iavarone, A. T., and Portnoy, D. a (2010). c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328, 1703-5. doi:10.1126/science.1189801.
127. Wu, J., and Chen, Z. J. (2014). Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461-88. doi:10.1146/annurev-immunol-032713-120156.
128. Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., and Chen, Z. J. (2013). Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-30. doi:10.1126/science.1229963.
129. Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., and Shu, H.-B. (2005). VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-40. doi:10.1016/j.molcel.2005.08.014.
130. Yang, J.-F., Hsieh, M.-Y., Hou, N.-J., Dai, C.-Y., Huang, J.-F., Lin, Z.-Y., Chen, S.-C., Wang, L.-Y., Chuang, W.-L., and Yu, M.-L. (2009). Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice. Aliment. Pharmacol. Ther. 29, 1000- 10. doi:10.1111/j.1365-2036.2009.03957.x.
131. Yang, P., An, H., Liu, X., Wen, M., Zheng, Y., Rui, Y., and Cao, X. (2010). The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol. 11, 487-94. doi:10.1038/ni.1876.
132. Ying, F., Chalise, J. P., Narendra, S. C., and Magnusson, M. (2011). Type I IFN protects against antigen-induced arthritis. Eur. J. Immunol. 41, 1687-95. doi:10.1002/eji.201040956.
133. Yu, J., de Belle, I., Liang, H., and Adamson, E. D. (2004). Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol. Cell 15, 83-94. doi:10.1016/j.molcel.2004.06.030.
134. Zhang, X., Shi, H., Wu, J., Zhang, X., Sun, L., Chen, C., and Chen, Z. J. (2013). Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226-35. doi:10.1016/j.molcel.2013.05.022.
135. Zhang, Y., Thai, V., McCabe, A., Jones, M., and Macnamara, K. C. (2014). Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis. Infect. Immun. 82, 1698- 709. doi:10.1128/IAI.01564-13.
136. Zhang, Z., Yuan, B., Bao, M., Lu, N., Kim, T., and Liu, Y.-J. (2011). The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959-65. doi:10.1038/ni.2091.
137. Zheng, S.-J., Jiang, J., Shen, H., and Chen, Y. H. (2004). Reduced Apoptosis and Ameliorated Listeriosis in TRAIL-Null Mice. J. Immunol. 173, 5652-5658. doi:10.4049/jimmunol.173.9.5652.